Serious Oral Minoxidil Side Effects
    7/23/2021

    From the encyclopedia
    Dutasteride β†’

    Heavy duty finasteride that comes with higher risks

    Minoxidil β†’

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this side effect report post, the primary subjects mentioned are
    πŸ’Š Dutasteride (oral) 0.6 mg 1 month
    πŸ’Š Minoxidil (oral) 2.5 mg 1 month
    πŸ’Š Minoxidil (oral) 5 mg 1 week
    πŸ’§ Minoxidil (topical) 1 year
    the tone is 😞 negative.

    Other terms

    A user experienced severe side effects, including heart-related symptoms, after increasing their oral minoxidil dosage to 5 mg, leading them to stop the medication and seek medical advice. Many users advised against high doses of oral minoxidil, suggesting anxiety as a possible cause, and recommended consulting a doctor or switching to topical treatments.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Male And Female Pattern Hair Loss

      research Male and female pattern hair loss

      June 2025 in “Australian Prescriber”
      In this study, the authors highlighted treatments for androgenetic alopecia, noting that combination therapies with drugs like minoxidil and antiandrogens often require at least 6 months for clinical improvement, while also emphasizing the value of patient counseling for informed treatment choices.
      Atlas of Geriatric Dermatology

      research Atlas of Geriatric Dermatology

      2 citations , January 2014 in “Springer eBooks”
      The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.
      Chemotherapy and Cutaneous Drug Reactions

      research Chemotherapy and Cutaneous Drug Reactions

      1 citations , January 2015 in “Springer eBooks”
      Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.
      Dermatologic Manifestations of Polycystic Ovary Syndrome

      research Dermatologic Manifestations of Polycystic Ovary Syndrome

      76 citations , January 2007 in “American Journal of Clinical Dermatology”
      This review discusses the dermatologic features of PCOS as potential early indicators of the syndrome and notes that treatment of these conditions may enhance quality of life and psychological well-being, but it reports no new clinical results.
      Chemotherapy-Induced Alopecia

      research Chemotherapy-induced alopecia

      103 citations , December 2011 in “Journal of the American Academy of Dermatology”
      This review discusses current knowledge and management strategies for chemotherapy-induced alopecia, highlighting the need for better research prioritization and providing patient support materials, but reports no new clinical results.